Literature DB >> 6291454

Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.

H C Neu.   

Abstract

The beta-lactamase inhibitors clavulanic acid and sulbactam were combined with mecillinam. beta-Lactamase-containing Escherichia coli resistant to mecillinam was synergistically inhibited by both clavulanic acid and sulbactam. beta-Lactamase-containing Enterobacter was synergistically inhibited, but strains lacking beta-lactamases were not synergistically inhibited. Synergistic inhibition was noted for beta-lactamase-containing, mecillinam-resistant Klebsiella, Citrobacter, Serratia, and Salmonella isolates, but only 18% of beta-lactamase-containing Proteus mirabilis, Providencia rettgeri, Providencia stuartii, and Morganella morganii were synergistically inhibited by the combinations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291454      PMCID: PMC183776          DOI: 10.1128/AAC.22.3.518

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Naturally-occurring beta-lactamase inhibitors with antibacterial activity.

Authors:  A G Brown; D Butterworth; M Cole; G Hanscomb; J D Hood; C Reading; G N Rolinson
Journal:  J Antibiot (Tokyo)       Date:  1976-06       Impact factor: 2.649

2.  Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.

Authors:  A R English; J A Retsema; A E Girard; J E Lynch; W E Barth
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

4.  In vitro studies with mecillinam on Escherichia coli and Pseudomonas aeruginosa.

Authors:  M H Richmond
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

5.  Comparative inhibition beta-lactamases by novel beta-lactam compounds.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

6.  A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.

Authors:  N Aswapokee; H C Neu
Journal:  J Antibiot (Tokyo)       Date:  1978-12       Impact factor: 2.649

7.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

8.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

  8 in total
  1 in total

Review 1.  Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review.

Authors:  Filip Jansåker; Niels Frimodt-Møller; Thomas L Benfield; Jenny Dahl Knudsen
Journal:  Infect Drug Resist       Date:  2018-05-24       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.